Novavax, Inc. (NASDAQ:NVAX) BofA Securities 2023 Health Care Conference May 11, 2023 1:00 PM ET
Company Participants
John Jacobs - President & Chief Executive Officer
Filip Dubovsky - President-Research and Development
Conference Call Participants
Alec Stranahan - Vice President & Senior Biotech Analyst
Alec Stranahan
Hey, everyone. Good afternoon and welcome to -- or I guess good morning. Welcome to day three of the 2023 BofA Healthcare Conference. Thanks for joining the session with Novavax.
My name is Alec Stranahan. I'm Vice President and Senior Biotech Analyst covering Novavax at BofA. And I'm pleased to be joined by John Jacobs, President and Chief Executive Officer of Novavax as well as Filip Dubovsky, Executive Vice President and Chief Medical Officer. Thanks for being here guys.
John Jacobs
Our pleasure. And thanks to those of you who joined us live as well. This is one of the last sessions of the conference. I appreciate you being here.
Alec Stranahan
Saving the best for last. Yes.
Question-and-Answer Session
Q - Alec Stranahan
Yes. So let's just jump into it. We've got 30 minutes for Q&A. But if there's any questions from the audience just feel free to raise your hand throughout and you'll be brought a microphone and you can ask your question. So maybe just to start John, you're new to the company you've been you now have a quarter plus of your...
John Jacobs
Yes. About 12 weeks.
Alec Stranahan
Yes, under your belt. So how have the first few months on the job been at Novavax and what have you guys accomplished and what's your key focus next six months?
John Jacobs
I would say exhilarating. We've accomplished a lot in 12 weeks and moved very quickly. And I came to the company because I really believe in the science. I did an
- Read more current NVAX analysis and news
- View all earnings call transcripts